These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25884459)

  • 21. Urinary vitamin D-binding protein, a novel biomarker for lupus nephritis, predicts the development of proteinuric flare.
    Go DJ; Lee JY; Kang MJ; Lee EY; Lee EB; Yi EC; Song YW
    Lupus; 2018 Sep; 27(10):1600-1615. PubMed ID: 29958502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis.
    Moroni G; Radice A; Giammarresi G; Quaglini S; Gallelli B; Leoni A; Li Vecchi M; Messa P; Sinico RA
    Ann Rheum Dis; 2009 Feb; 68(2):234-7. PubMed ID: 18718989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction Of Renal Flare In Adult Patients With Lupus Induced Nephritis.
    Batool H; Naseem T; Shoukat M
    J Ayub Med Coll Abbottabad; 2021; 33(1):9-13. PubMed ID: 33774946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monocyte chemoattractant-1 as a urinary biomarker for the diagnosis of activity of lupus nephritis in Brazilian patients.
    Rosa RF; Takei K; Araújo NC; Loduca SM; Szajubok JC; Chahade WH
    J Rheumatol; 2012 Oct; 39(10):1948-54. PubMed ID: 22942263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic and Diagnostic Values of Novel Serum and Urine Biomarkers in Lupus Nephritis: A Systematic Review.
    Radin M; Miraglia P; Barinotti A; Fenoglio R; Roccatello D; Sciascia S
    Am J Nephrol; 2021; 52(7):559-571. PubMed ID: 34515043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IFN-γ, CXCL16, uPAR: potential biomarkers for systemic lupus erythematosus.
    Wen S; He F; Zhu X; Yuan S; Liu H; Sun L
    Clin Exp Rheumatol; 2018; 36(1):36-43. PubMed ID: 28628472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum thiols as a biomarker of disease activity in lupus nephritis.
    Lalwani P; de Souza GK; de Lima DS; Passos LF; Boechat AL; Lima ES
    PLoS One; 2015; 10(3):e0119947. PubMed ID: 25799079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide.
    Dall'Era M; Stone D; Levesque V; Cisternas M; Wofsy D
    Arthritis Care Res (Hoboken); 2011 Mar; 63(3):351-7. PubMed ID: 21080348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.
    Schwartz N; Rubinstein T; Burkly LC; Collins CE; Blanco I; Su L; Hojaili B; Mackay M; Aranow C; Stohl W; Rovin BH; Michaelson JS; Putterman C
    Arthritis Res Ther; 2009; 11(5):R143. PubMed ID: 19785730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE Cohort Study.
    Smith EMD; Jorgensen AL; Beresford MW;
    Lupus; 2017 Oct; 26(11):1212-1217. PubMed ID: 28385126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary prostaglandin D synthase as biomarker in lupus nephritis: a longitudinal study.
    Gupta R; Yadav A; Misra R; Aggarwal A
    Clin Exp Rheumatol; 2015; 33(5):694-8. PubMed ID: 26211517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colony-stimulating factor-1: a potential biomarker for lupus nephritis.
    Menke J; Amann K; Cavagna L; Blettner M; Weinmann A; Schwarting A; Kelley VR
    J Am Soc Nephrol; 2015 Feb; 26(2):379-89. PubMed ID: 25012167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-C1q antibodies, sCD40L, TWEAK and CD4/CD8 ratio in systemic lupus erythematosus and their relations to disease activity and renal involvement.
    ElGendi SS; El-Sherif WT
    Egypt J Immunol; 2009; 16(1):135-48. PubMed ID: 20726330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of progranulin in patients with lupus nephritis and its correlation with disease activity.
    Wu J; Wei L; Wang W; Zhang X; Chen L; Lin C
    Rheumatol Int; 2016 Jun; 36(6):759-67. PubMed ID: 26968845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of cytokines as biomarkers in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; Borozdenkova S; Karim MY
    Nephrol Dial Transplant; 2011 Oct; 26(10):3273-80. PubMed ID: 21372259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using plasma circRNA_002453 as a novel biomarker in the diagnosis of lupus nephritis.
    Ouyang Q; Huang Q; Jiang Z; Zhao J; Shi GP; Yang M
    Mol Immunol; 2018 Sep; 101():531-538. PubMed ID: 30172209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimation of kidney injury molecule-1 (Kim-1) in patients with lupus nephritis.
    Nozaki Y; Kinoshita K; Yano T; Shiga T; Hino S; Niki K; Kishimoto K; Funauchi M; Matsumura I
    Lupus; 2014 Jul; 23(8):769-77. PubMed ID: 24598218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lupus nephritis biomarkers.
    Soliman S; Mohan C
    Clin Immunol; 2017 Dec; 185():10-20. PubMed ID: 27498110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.